Elite Pharms Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Sales | 5,015 | 4,601 | 3,404 | 2,424 | 4,266 |
| Cost of Goods | 3,014 | 3,236 | 2,315 | 1,014 | 2,675 |
| Gross Profit | 2,002 | 1,365 | 1,088 | 1,410 | 1,591 |
| Operating Expenses | 18,522 | 6,885 | 2,967 | 3,390 | 3,152 |
| Operating Income | -16,507 | -5,284 | -1,563 | -1,966 | -886 |
| Interest Expense | 287 | 900 | 393 | 654 | 1,491 |
| Other Income | 22,012 | -35,370 | 3,090 | -12,922 | -11,507 |
| Pre-tax Income | 5,217 | -41,554 | 1,134 | -15,542 | -13,884 |
| Income Tax | -3 | -293 | -354 | -484 | -301 |
| Net Income Continuous | 5,221 | -41,261 | 1,488 | -15,058 | -13,582 |
| Net Income | $5,221 | $-41,261 | $1,488 | $-15,058 | $-13,582 |
| EPS Basic Total Ops | 0.05 | -0.21 | 0.00 | -0.06 | -0.14 |
| EPS Basic Continuous Ops | 0.01 | -0.09 | 0.00 | -0.06 | -0.14 |
| EPS Diluted Total Ops | -0.02 | -0.21 | 0.00 | -0.06 | -0.14 |
| EPS Diluted Continuous Ops | 0.01 | -0.09 | 0.00 | -0.06 | -0.14 |
| EBITDA(a) | $-15,925 | $-4,830 | $-1,140 | $-1,482 | $-402 |